Home › Research › Disparities
Global, Regional, and National Disparities in the Burden of Alzheimer’s Disease and Other Dementias, 1990–2021
Meiling Hu, Tongyun Wang, Jing Song, Ningrui Liu, Yuhong Zeng, Danqing Hu, Yang Guo, Jie Chang et al.. Neuroepidemiology, 2025-12-19
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
In 2021, the age-standardised rates for ADOD were 694.01 (95% uncertainty intervals [UIs]: 602.88 to 794.08) for prevalence, 119.76 (95% UI: 104.96 to 135.89) for incidence, and 481.70 (95% UI: 228.79 to 1,023.96) for disability-adjusted life years (DALYs). Females exhibited a higher ADOD burden than males across all age groups, with an age-standardised prevalence rate of 769.94 (95% UI: 670.71 to 877.57) in females compared to 589.47 (95% UI: 507.48 to 678.79) in males. The slope inequality index of crude DALY rate increased from 315.23 (95% confidence intervals [CIs]: 310.43 to 437.87) in 1990 to 758.29 (95% CI: 692.48 to 908.29) in 2021 at the country level. The Lorenz curves for the crude DALY rate of ADOD in 1990 and 2021 lay below the equality line, indicating a higher burden among countries and territories with a higher socio-demographic index (SDI) ranking. By 2046, global prevalence is projected to reach 124.89 million, a 119.67% increase from 2021. The ADOD burden has increased globally, with significant regional disparities. Urgent action is required to prevent ADOD, especially among females and in high-SDI regions.
What this study adds
Evidence grade: Moderate
This global analysis found that the burden of Alzheimer's disease and other dementias increased from 1990 to 2021, with females carrying a higher burden than males across all age groups. Reported effect size: 119.67%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hu, M., Wang, T., Song, J., Liu, N., Zeng, Y., Hu, D., et al. (2025). Global, Regional, and National Disparities in the Burden of Alzheimer’s Disease and Other Dementias, 1990–2021. Neuroepidemiology. https://doi.org/10.1159/000549854
Vancouver
Hu M, Wang T, Song J, Liu N, Zeng Y, Hu D, et al. Global, Regional, and National Disparities in the Burden of Alzheimer’s Disease and Other Dementias, 1990–2021. Neuroepidemiology. 2025. doi:10.1159/000549854. PMID: 41417684.
BibTeX
@article{hu2025-41417684,
author = {Hu, Meiling and Wang, Tongyun and Song, Jing and Liu, Ningrui and Zeng, Yuhong and Hu, Danqing and Guo, Yang and Chang, Jie and others},
title = {{Global, Regional, and National Disparities in the Burden of Alzheimer’s Disease and Other Dementias, 1990–2021}},
journal = {Neuroepidemiology},
year = {2025},
doi = {10.1159/000549854},
pmid = {41417684},
url = {https://doi.org/10.1159/000549854}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- In 2021, the age-standardised rates for ADOD were 694.01 (95% uncertainty intervals [UIs]: 602.88 to 794.08) for prevalence, 119.76 (95% UI: 104.96 to 135.89) for incidence, and 481.70 (95% UI: 228.79 to 1,023.96) for disability-adjusted life years (DALYs).
- Females exhibited a higher ADOD burden than males across all age groups, with an age-standardised prevalence rate of 769.94 (95% UI: 670.71 to 877.57) in females compared to 589.47 (95% UI: 507.48 to 678.79) in males.
- The slope inequality index of crude DALY rate increased from 315.23 (95% confidence intervals [CIs]: 310.43 to 437.87) in 1990 to 758.29 (95% CI: 692.48 to 908.29) in 2021 at the country level.
- The Lorenz curves for the crude DALY rate of ADOD in 1990 and 2021 lay below the equality line, indicating a higher burden among countries and territories with a higher socio-demographic index (SDI) ranking.
- By 2046, global prevalence is projected to reach 124.89 million, a 119.67% increase from 2021.
Why it matters
This global analysis found that the burden of Alzheimer's disease and other dementias increased from 1990 to 2021, with females carrying a higher burden than males across all age groups. It projects global prevalence will reach 124.89 million by 2046 and calls for urgent action, especially among females and in high-SDI regions.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Effect size119.67%
- Evidence strengthModerate
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neuroepidemiology) |
| Journal's citation record | 1 / 4 | Neuroepidemiology: journal h-index 125 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Zhennan Lin: h-index 7 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | University of Washington: institution h-index 3,540 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 14 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41417684) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Disparities from nearby years
Also in Disparities
98 studies in the library are filed under Disparities with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Disparities hub.